Syncona Limited (SYNC) Ordinary NPV

Syncona Limited is a Guernsey-based closed-ended investment company. The Company’s investment objective is to achieve superior long-term capital appreciation from its investments. It seeks to achieve returns over the long term. The Company invests in life science businesses (including private and quoted companies) and single or multi-asset projects. It focuses on creating, building and scaling companies around science to create a diversified portfolio of 20-25 global healthcare businesses, across development stage and therapeutic areas. It focuses on developing treatments for patients by working in close partnership with academic founders and management teams. The Company makes its life science investments through Syncona Holdings Limited, a subsidiary of the Company. It maintains its capital pool through Syncona Investments LP Incorporated (the Partnership), in which the Company is the sole limited partner. Syncona Investment Management Limited is its investment manager.

The Company’s investment objective is to achieve superior long-term capital appreciation from its investments. The Company invests in life science businesses and single or multi-asset projects. The Company targets an annualised return per share across its investment portfolio of 15 per cent per annum over the long term.

• Ongoing charge1.84%
• Annual management charge -
• Performance feeNo

The company will pay SIML an annual fee